Results for tag: "Postoperative Ileus Drug"

Postoperative Ileus (POI) is a common complication of abdominal surgery, characterized by a temporary cessation of intestinal motility. It is a major cause of morbidity and mortality in the postoperative period, and is associated with prolonged hospital stays and increased healthcare costs. Gastrointestinal drugs are used to treat POI, and include prokinetic agents, anticholinergics, and opioid antagonists. Prokinetic agents, such as erythromycin and metoclopramide, are used to stimulate gastrointestinal motility, while anticholinergics, such as hyoscine, are used to reduce spasms of the gastrointestinal tract. Opioid antagonists, such as naloxone, are used to reverse the effects of opioids on the gastrointestinal tract. Companies in the Postoperative Ileus Drug market include AstraZeneca, GlaxoSmithKline, Merck & Co., Pfizer, and Sanofi. Show Less Read more